Top Markets
Coin of the day
Modalis Therapeutics Corporation Modalis Therapeutics Corporation

Modalis Therapeutics Corporation

4883
Rankning i aktier #29676
Modalis Therapeutics Corporation focuses on discovering and developing... Modalis Therapeutics Corporation focuses on discovering and developing treatments for severe genetic conditions. The company utilizes its proprietary CRISPR-GNDM technology to create therapies by controlling gene expression through the epigenetic modulation of specific genetic loci. Modalis also has a collaborative research agreement with JCR Pharmaceuticals Co., Ltd., aimed at assessing gene therapy drug delivery methods for the central nervous system (CNS), particularly for CNS-related disorders. Founded in 2016, the company was initially known as EdiGENE Corporation before changing its name to Modalis Therapeutics Corporation in August 2019. Its operations are based in Tokyo, Japan.
Aktiekurs
$0.20877985
Marknadsvärde
$20.11M
Förändring (1 dag)
-3.03%
Förändring (1 år)
-66.13%
Land
JP
Handel Modalis Therapeutics Corporation (4883)

Kategori

Historik för aktiesplit för Modalis Therapeutics Corporation (4883)
Aktien Modalis Therapeutics Corporation (symbol: 4883) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 19, 2026.
En 4883-aktie köpt före Aug 19, 2026 motsvarar nu 0 4883-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR